MedTrace Logo

PINPOINT: Gaming Technology for SCD Pain

NCT04579926 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-05-01

Study results available
· View outcomes & findings →

Summary

Sickle cell disease (SCD) is a common genetic disorder characterized by episodes of pain, yet programs to assist SCD adolescents with better identification and communication about pain are lacking. Research shows that interactive gaming technology can enhance adolescents' learning, and can be especially effective in delivering health-related messages and tools to improve self-care. Pinpoint is an interactive gaming app that will be tested in a Phase II project to determine whether the app assists SCD teens with improving their communication and identification skills for pain self-report.

Conditions

  • Sickle Cell Disease
  • Sickle Cell Anemia in Children
  • Sickle Cell Thalassemia
  • Sickle Cell SC Disease

Interventions

OTHER

Pinpoint app

Tablet and smartphone app with pain assessment and communication education, and pain assessment tool.

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • HPC International, Inc.

    collaborator INDUSTRY

  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • Valerie Myers, PhD · Klein Buendel, Inc.

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-19
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579926 on ClinicalTrials.gov